|
Method of treating blepharoconjunctival form of dry eye syndrome |
|
IPC classes for russian patent Method of treating blepharoconjunctival form of dry eye syndrome (RU 2510701):
Ophthalmic compositions of tamarind seed polysaccharide and hyaluronic acid / 2493855
Group of inventions refers to ophthalmology. The ophthalmic preparations are used in ophthalmic diseases as a lacrimal substitute, and they contain a combination of hyaluronic acid and a polysaccharide known as TSP (a Tamarindus indica seed polysaccharide). The ophthalmic preparations suggested to be used in treating a dry eye syndrome contain in a combination of 0.05 to 2 wt % of the tamarind seed polysaccharide and 0.05 to 1 wt % of hyaluronic acid in the aqueous solution.
Aqueous pharmaceutical compositions containing borate-polyol complexes / 2477631
Invention refers to a multidose ophthalmic composition containing prostaglandin as a therapeutic ingredient, mannitol or sorbitol 0.15-0.5 wt/vol %, propylene glycol or glycerol 0.2-1.8, borate 0.25-0.5 wt/vol %, an antimicrobial preserving agent 0.0003-0.003 wt/vol % representing a polymer quaternary ammonium compound and water. Said composition has pH 6.4-7.2 and is benzalconium chloride free. Besides, the invention refers to the use of said ophthalmic composition for preparing a drug for treating glaucoma, eye infections, allergies and inflammations.
Methods and compositions for treating dry eye / 2470662
Group of invention refers to ophthalmic compositions containing protease inhibition peptide substrates. The ophthalmic compositions contains a peptide substrate in a solution in the amount of approximately 0.01 wt/vol. % to 10 wt/vol. %, and said substrate is specified in a group consisting of gelatin, ovomacroglobulin, collagen and casein in an ophthalmically acceptable carrier. The composition additionally contains galactomannan and borate. The invention also describes a method for using the composition for treating dry eye.
Aqueous pharmaceutical suspension containing rebamipide, and method for preparing it / 2467751
Invention refers to an aqueous pharmaceutical suspension which contains a fine rebamipide of particle size 0.2-5 mcm and polyvinyl alcohol. The invention also refers to a method for preparing said rebamipide suspension which involves mixing water and polyvinyl alcohol to prepare an aqueous solution, adding fine rebamipide particles to said solution, and mixing to produce the aqueous rebamipide suspension.
Ophthalmologic composition with amphoteric surface-active substance hyaluronic acid / 2448736
Group of inventions relates to medicine, in particular, to ophthalmology. Ophthalmologic compositions contain from 0.1 ppm to 10 ppm of cationic antimicrobial component, selected from group, consisting of biguanides, polymer biguanides, quaternary ammonium compounds and any their mixture; 0.005-0.15 wt % of hyaluronic acid; and 0.01-1.0 wt % of amphoteric surface-active substance of formula I, where R1 represents R or -(CH2)n-NHC(O)R, where R represents C8-C18 alkyl, which can be replaced by hydroxyl group and equals 2, 3 or 4; R2 and R4 each is independently selected from methyl, ethyl, propyl or isopropyl; and R4 represents C2-C8 alkylene, which can be substituted by hydroxyl group.
Liquid aqueous ophthalmic composition / 2445950
Group of inventions refers to medicine, particularly to ophthalmology. An aqueous liquid ophthalmic composition contains hyaluronic acid in the concentration of 0.05-0.4% or its pharmaceutically acceptable salt, and additionally contains gluconic acid and its salt with a metal, but does not contain chlorhexidine or its salt. A method for improving the viscosity stability of the aqueous eye-drop ophthalmic composition containing hyaluronic acid is conditioned by introducing gluconic acid and its salt with the metal.
Method for prevention radiation lesions of lachrymal ducts / 2445941
Invention refers to medicine, namely oncology, and may be used in treating eyelid cancer for prevention of obliteration of the lachrymal ducts. That is ensured by irrigation of the nasolachrymal duct twice a day before each session radiation therapy and in 10-12 days after the session. A solution containing 0.1% dexamethasone min. 2.0 ml and methotrexate 5 mg is injected in the nasolachrymal duct in a lower nasal point through a blunt-ended cannula on a syringe.
Eye drops / 2431470
Invention refers to pharmaceutical industry and medicine, and concerns a lachrymal substitute preparation which can be used for local therapy in an ocular surface disease. The invention has a composition (g/l): hydroxypropyl methylcellulose 2.5-5.0; disodium phosphate 5.5-16.5; sodium dihydrogen phosphate 0.8-1.5; sodium chloride 2.0-8.0; disodium edetate 0.1-0.5; benzalkonium chloride 0.03-0.09; dextrane 0.5-1.5; water for injections up to 1 l. The composition has the balanced proportions providing the pH value within 6.5 to 7.8, contains a polymeric composition containing hydroxypropyl methylcellulose and dextrane. As dextrane, either dextrane 40, or dextrane 60, or dextrane 70 is used.
Method of increasing ophthalmosurgery safety by ml kashkovskiy / 2414196
Invention relates to medicine, ophthalmology, and can be used in diagnostics and surgical treatment of vision organ diseases. In realisation of the method instruments, products of medicinal purpose and liquids introduced into eye are used heated to +37°C. Open eyeball is irrigated from above with 0.9% of sodium chloride at temperature +37°C continuously by means of dropper with frequency 12 drops per minute, and illuminated by yellow dispersed light with wavelength 570-590 nm. Light formation is provided by light filter. Light brightness is increased under control of visibility of selected eye structures to minimal value, ensuring their visibility.
Preventive or therapeutic agent for treatment of keratoconjuctival disorders / 2406499
There is offered an agent for treatment of dry eye syndrome, superficial punctuate keratopathy, corneal epithelium defect, corneal erosion, corneal ulcer, conjunctival epithelium defect, dry keratoconjunctiva, superior limbic keratoconjunctivitis, filamentous keratoconjunctivitis, keratitis or conjunctivitis, containing 2-phenyl-1,2-benzisoselenazol-3(2H)-one (ebselen) or its salts as an active ingredient, its administration and an appropriate therapy.
Method for preparing saponin-containing extracts (versions) / 2510278
Invention refers to pharmaceutical industry, namely to a method for preparing a saponin-containing extract. The method for preparing the saponin-containing extract containing pre-soaking of Saponaria officialis L. roots in distilled water, ultrasonic extraction, filtration in the specific environment.
Immunostimulating drug / 2510277
Invention refers to an immunostimulating drug on the basis of a herbal alcohol tincture. The above drug is prepared by filling the herbal raw material with 70% ethanol in the ratio of 1:10, keeping in a dark place at temperature 18-20°C for 7 days, filtering, extracting the raw material, and filtering the extract. The herbal raw material contains purple Echinacea herb and blossom clusters, Scotch pine buds, horseheal roots and rhizomes, common licorice roots and harmel herb taken in 1:1:1:1:0.5.
Method for preparing pectin gel of elevated part of willow herb / 2510275
Invention refers to a method for preparing a pectin gel of an elevated part of willow herb. The declared method enables dissolving pre-recovered pectin from the elevated part of willow herb in water, cooling and applying onto a frozen chitosan solution and further gel formation.
Oral composition / 2510262
Group of inventions refers to medicine, namely to dentistry, and may be used as an oral composition for controlling an oral sweetener release. The above composition contains a polymer attached to the sweetener by a breakable link comprising a covalent bond, an ester bond or an amide bond. The breakable link is breakable in the oral cavity to release the sweetener. Said polymer is a polymer adhered to the mucosa and specified in methyl vinyl ether/maleic anhydride copolymer with polymer found in the amount of 0.001% to 10%. The sweetener is specified in dextrose, saccharose, maltose, dextrin, dried invert suger, mannose, xylose, ribose, fructose, lexulose, galactose, corn syrup, partially hydrolysed starch, sorbitol, mannitol, isomalt, aspartame, neotame, saccharine and its salts, sucralose, the sweeteners on the basis of dipeptides, cyclamates, dihydrochalcone with the sweetener content making 0.005% to 5%. What is also presented is a portable dispenser, a method for preparing the oral composition, a method for controlling the sweetener in the oral cavity, and using the polymer.
Composition for treating and preventing osteoarthritis and osteoarthrosis / 2509569
Invention refers to pharmaceutical industry, namely to a composition for treating and preventing osteoarthritis and osteoarthrosis. The composition for treating and preventing osteoarthritis and osteoarthrosis contains a powder or an extract of a dry plant specified in a group: burdock, dandelion, cowberry, birch, St.-John's wort, golden-rod, nettle, peppermint, licorice, cinquefoil, tormentil, brier, Greek valerian, valerian, corn, holy thistle, oat, agrimony, everlasting flower, ginseng, sage, starwort, squash, willow, wild strawberry, chicory, wheat-grass, artichoke, bilberry, marigold, horse radish, garlic, aspen, knotgrass, plantain, inula, Fagopyrum rubricaulis, chamomile, balm lemon, blue poppy, cudweed, tripartite bur-marigold; a male larval bee lyophilisate and a quercetine or dihydroquercetine, or rutin powder in certain proportions.
Method for correction of total blood serum baee-esterase activity using soya protein isolate / 2509568
Method refers to preventive medicine and concerns decreasing total BAEE-esterase activity. For this purpose, soya protein isolate 30 gram has been daily introduced into the subjects for 2 months.
Method for preparing cake shelf fungus extract / 2509567
Invention refers to pharmaceutical, food and cosmetic industry and concerns preparing a cake shelf fungus extract. The method for preparing the cake shelf fungus extract involving freezing cake shelf fungus, wetting it with a water solution containing dimethyl sulphoxide and sodium hydroxide, with a solution temperature being 50-90°C, and keeping at the above temperature for 1-2 hours.
Compositions of borinic acid / 2509553
Invention refers to pharmaceutical industry and represents an oral care composition having pH min. 8 or buffered so that to maintain the pH value min. 7, containing 3- hydroxypyridine-2-carbonyloxy-bis-(3-chlor-4-methylphenyl)borane in a combination or together with an orally acceptable carrier.
Composition applicable as personal hygiene product and methods for using it / 2509552
Invention refers to cosmetology and represents a composition applicable by a user as a personal hygiene product in the form of a bath or shower gel, containing: (a) no more than 11.5 wt % of an anionic surfactant representing alkyl sulphate, alkyl sarcosinate, or any combination thereof; (b) no more than 3 wt % of a zwitterionic surfactant representing fatty acid amidoalkylbetaine, (c) not less than 0.1 wt % of a hydroxyalkylcellulose derivative with a long-chain alkyl group; and (d) water.
Method of human health improvement / 2509547
Invention refers to medicine, namely recreation therapy, and may be used for human health improvement. That is ensured by traditional medical examination of the patient. The findings are used to draw up the rehabilitation program including body cleansing, intestine and liver purification, physical exercises. One week before the beginning of the rehabilitation program, the patient starts separate nutrition with preferential vegetable food and dairy products, limited consumption of salt, alcohol and sugar. One day before the rehabilitation program, a fasting day is kept with taking 1% kephir or fresh apple juice. Further, on the first two days of the three-day program or on the first four days of the seven-day program, the body is cleansed by keeping a juice diet. The juice diet contains fresh vegetable and fruit juices, herbal infusions and mineral water. Water is unlimited. On the first day of the cleansing program, the intestine is purified with the preparation Fortrans. Starting from the first day the liver and gall bladder are cleansed with using herbal and saline choleretics for four days of the 7-day program and for two days of the 3-day program. That is combined with paradoxical respiration by Strelnikova's technique and hydrotherapy. Physical exercises involve physical loads on a cardio-vascular machine, one training as prescribed by the doctor - yoga, pilates, chi gong, water aerobics or hypoxi capsule. Therapeutic massage and lymph drainage massage follow. Then body-detox, ozone therapy, collagenarium procedures are performed. Cold training procedures involve Linear Kneipp, saunas, swimming pool, turpentine bathes. Bathing and cold training procedures are followed by pilling and algae wraps. From the 5th day of the 7-day program, or from the 3rd day of the 3-day program, the diet involves water cereals, vegetable and fruit salads, vegetable fast soups.
Medical gel for erythrocyte and leukocyte separation by centrifugation / 2494788
Invention refers to a medical gel for erythrocyte and leukocyte separation, and may be used in preparing plasma to be used in plasmolifting technique. The gel contains, wt %: the gelling agent - polyisobutylene - 58.5 - 59.5; the dissolving agent - chlorinated paraffin - 19.5 - 20.5; the chemically and biologically inert filler - silicon dioxide - 13.0 - 14.0; the plasticising agent - propylene glycol adipic acid. The gel is used to prepare plasma for erythrocyte and leukocyte separation by centrifugation.
|
FIELD: medicine. SUBSTANCE: eyelid care is performed daily twice a day for one month in the form of a 1-2-minute Blepharowipe stupe. That is followed by a 1-2-minute eyelid self-massage with Blepharogel 1 or Blepharogel 2. Systane Balance artificial tear drops are instilled into a conjunctival cavity every 4 hours 3 times a day. The instillations are alternated with eye blinking exercises for 15 seconds 3 times a day. The therapeutic course is repeated one month later. EFFECT: recovered functional state of the lipid layer of the tear film with an increase in the protective function of tears and relevant reduction of the clinical manifestations of the degenerative and inflammatory processes in the eyelids, conjunctiva and cornea due to an interaction of the procedures of the method each of which enhances the effect of the following one. 2 cl, 3 ex
The invention relates to ophthalmology and is intended for treatment of blepharoconjunctivitis forms of dry eye syndrome that develops as a result of inflammatory processes, infectious and non-infectious origin, eyelids and conjunctiva, as well as the negative impact of environmental factors on ocular surface. Inflammation of the eyelids and conjunctiva entail a violation of the functional state marojevic glands and the lacrimal film, therefore, to develop blepharoconjunctivitis forms of dry eye syndrome. Thus, therapeutic and preventive procedures aimed at restoring functional status marojevic glands and the lacrimal film, as well as reducing the impact of environmental factors, will prevent further development blepharoconjunctivitis forms of dry eye syndrome. The latest knowledge and technology have significantly changed views on the etiology and pathogenesis in the pathological process associated with changing lesoproduktsii. So, until recently it was believed that the main reason for the development of dry eye syndrome is a systemic disease that violate the products of aqueous component of the tear film. Now we know that what used to be called a syndrome of "dry eye" is actually p is ecstasy a nosological group. This group is polymorphic, and its frequency of occurrence, especially in outpatient practice, high and ranges from 25 to 37%. Among the diverse clinical manifestations of diseases of the eyeball, of course, there is such symptom is dryness of the eyes. However, the syndrome of "dry eye" as nosological form is not the only symptom is a complex pathology, and not just a deficit of water component tears. It should be noted that most authors note that the most frequent reason for reducing the stability of the tear film and changes in its functional state is dysfunction marojevic glands, which occurs in more than 90% of patients with dry eye syndrome. Meibomian glands are the main source of lipids for tear film person. The secret marojevic glands consists of a complex mixture of various polar and nonpolar lipids, containing cholesterol and wax esters, diesters, triacylglyceride, free cholesterol, free fatty acids and phospholipids. The secret is distributed on the tear film and slows down the evaporation of the water component, retains the transparency of the optical surface and forms a barrier that protects the eyes from microorganisms and organic contaminants such as dust and pollen. Rapidly developing area, including complex hygienic the ski therapeutic and preventive procedures normalizes the stability of the tear film, which include research oftalmologica, allowing to minimize the negative impact of environmental factors on the organ of vision in conditions of high visual load, as a basis for developing practical recommendations. To date, however, was not considered complex carrying out the above methods of prevention and treatment of pathological processes of the ocular surface, manifested in the form blepharoconjunctivitis forms of dry eye syndrome. There is a method of treatment of dry eye syndrome using eye drops on the basis of a phospholipid in which physiological solution of sodium salts contained sialic (karamanova) acid, L-carnosine and sulfated glycosaminoglycans. As sulfated glycosaminoglycans used sodium salt of keratomalacia, and the sodium salt of chondroitin sulfate, at a certain ratio of components, which reduces evaporation of the tear film, as well as the prevention of pathological changes in the epithelial cells of the conjunctiva and cornea, which may follow damage to the corneal stroma. This method involves symptomatic therapy, the appointment slutslittle the th therapy does not resolve the main etiological factor, leading to the development of degenerative processes of the ocular surface (patent RU 2302231, 2006). The known method of complex treatment of dysfunction marojevic glands at UCG. To do this in one session consistently massages century, then treated roots of eyelashes with 0.5% solution of metronidazole, causing the skin age prenatal and provide exposure to an alternating magnetic field of strength 10 MT and a frequency of 17 Hz. While the sessions are conducted daily for 8-14 days. The method provides effective treatment due to the recovery of functional status marojevic glands and restore and stabilize the lipid layer of the tear film. However, the method requires special additional equipment, in addition to the normal slit lamp, as well as the need for these manipulations by an ophthalmologist, not an individual, which increases the complexity of the method (patent RU 2314102, 2006). There is a method of treatment of dysfunction marojevic glands in SHBG with massage marojevic glands for emptying the contents marojevic glands. However, this method is technically difficult to use and, as the previous one, involves the participation of a doctor and can not be done by an individual in the home application for the invention EN 92009808/14, 1992). The closest analogue of the invention I have is the way the same destination, containing a scheme of comprehensive treatment, including hygiene century. To do this, first on the ciliary eyelids cause beforelogin for 15-20 minutes. Then wash it with water and put on the ciliary edge of the century 2 drops of leverages-2. Then RUB it in and leave for 5 minutes. Then wash off with water and again put it there by 1 drop of 12 hours. Then the procedure was repeated. Conduct its daily treatment 2-3 months. In case of Demodex all repeat the treatment, the course of treatment is 2 weeks. The method provides effective treatment by cleansing the hair follicles century mite, normalization of marojevic glands with simultaneous recovery of the composition of the tear film. However, the proposed method does not generate a sufficient amount of lipid to stabilize the tear film on the entire period of wakefulness due to the large amount of time between treatments, also this method is too complex to use and takes too much time (patent RU 2312640, 2007). The objective of the invention is to develop a new comprehensive medical and hygienic treatment blepharoconjunctivitis forms of dry eye syndrome. The technical result of the invention is the recovery of the functional state of the lipid layer of the tear film with the enhancement of protective functions with the drive and the corresponding reduction of the clinical manifestations of degenerative and inflammatory processes in centuries, conjunctiva and the cornea. The technical result is achieved due to complex medical and hygienic effects on the lipid layer of the tear film using hygienic procedures, including wraps and massages century, therapeutic factor and gymnastics for eyes. The proposed method is technically simple to perform, takes a little time and allows patients immediately after these manipulations to feel symptomatic relief at the expense of complex restoration of the lipid layer of the tear film with complex health care procedures, including hygiene century: warm compresses with Blepharospasm and eyelids massage with Leveragein 1 or Leveragein 2; the use of tear replacement drug Sistan Balance, which includes the anionic lipids-stabilizing ophthalmic emulsion containing SE-guar gum, which replaces the lipid layer of the tear film, which allows you to restore the stability and functional status, as well as to reduce exposure to harmful environmental factors on the ocular surface, to arrest the development of degenerative processes of cellular structures of the cornea and conjunctiva and exercises for the eyes as blink for 15 seconds, 3 times a day. Our proposed method involves a course g is hygienic treatment-and-prophylactic procedures, including: within one month of daily twice daily implementation of hygiene century in the form of a warm compress with Blepharoceridae within 1-2 minutes of self-massage of the eyelids with Leveragein 1 or Leveragein 2 within 1-2 minutes; the instillation in the conjunctival cavity through every 4 hours 3 times a day classements Sistan Balance, and in the intervals between installations carrying out exercises for the eyes as blink for 15 seconds, 3 times a day. The method of treatment blepharoconjunctivitis forms of dry eye syndrome due to the complex restoration of the lipid layer of the tear film allows you to simultaneously reduce the negative impact of environmental factors on ocular surface, to improve the nutrition of the cornea and increase the protective properties of the tear film. So, hygiene century aimed at restoring function marojevic glands, softening its lipid secretion under the influence of temperature - warm compresses with Blepharoceridae that facilitates evacuation at a later stage - eyelids massage with Leveragein. Self-massage has a complex effect - promotes emptying marojevic glands, consequently, restores the lipid component of the tear film, cleanse the eyelid skin, improves blood circulation, which in turn reduces the level of inflammatory and allergic re is the capabilities and provides in the case of Bevarages 2 protivonematodoznae action. Instillation of classements Sistan Balance allow you to compensate for the lipid layer of the tear film dysfunction marojevic glands due to the action of the main chemical substances in their composition, - SE-guar, anionic phospholipid in combination with vaseline oils, emulsifiers and softening substance. Increasing the number of blinks contribute to the emptying marojevic glands, therefore, the restoration of the protective lipid layer of the tear film, the purification of the conjunctival cavity outflow of the liquid, maintaining the temperature of the ocular surface, the reduction of which leads to disruption of the functional state of the lipid layer of the tear film and the uniform distribution of the tear film on the ocular surface. The above sequence of steps is due to the fact that provides compensation of the lipid layer of the tear film during the day. The proposed method starts with a morning hygiene century, in which the lipid component of the tear film comes in tear fluid through the softening of lipids secreted meibomiae glands under the influence of the warm compresses with Blepharospasm and subsequent eyelids massage with Leveragein 1 or Leveragein 2, which facilitates the evacuation of melted lipids and stimulates their production. After a morning hygiene century is via every 4 hours in the conjunctival cavity installed the drug Sistan Balance, proteziruemyh the lipid layer of the tear film, with the aim of maintaining it in the proper amount, and in the intervals between installations conduct exercises for the eyes as blink for 15 seconds, 3 times a day for additional stimulation of production of lipids and their uniform distribution on the ocular surface. Before going to sleep nightly hygiene century, providing protection of the conjunctiva and cornea. Thus, the proposed method provides a comprehensive and phased restoration of the lipid layer of the tear film during the day, which prevents the development of corneal conjunctival xerosis. Just the way applied in the group, which included 34 patients. In the comparison group consisted of 29 patients with the same diagnosis who were treated in the treatment century alcoholic solution of calendula or ointment Demalon. The effectiveness of therapy in the group where treatment was conducted by our proposed method was significantly higher than in the comparison group and were manifested in the form of elimination of the complaint and the relief of clinical symptoms of blepharitis and DMG (absence of hyperemia and thickening of the eyelids, under pressure from the mouths of the ducts marojevic glands secret transparent conjunctiva pale pink). In the comparison group noted the preservation of the complaints about "dry" and the feeling of a foreign body in the eyes, saving the ISU is remii conjunctiva and others, therefore, recommended the continuation of the treatment approach, against which the above mentioned signs blepharoconjunctivitis forms of dry eye syndrome were stopped. Higher efficiency, manifested in the form of improved objective clinical indicators (Schirmer test, test for Norn, biomicroscopic picture is the absence of signs of inflammation of the eyelids, the opening of the ducts marojevic glands, facilitating the evacuation of the secret marojevic glands) and subjective indicators (complaints), identified patients who were prescribed a comprehensive regime that includes hygiene century, installation ophthalmic emulsion, Sistan Balance, protesilaus the lipid layer of the tear film, as well as exercises for the eyes with frequent mode blinking. The method is as follows. Start by doing warm compresses, for which Blepharocalyx, sealed, heated in a glass of hot water, then put on closed eyelids for 1-2 minutes, followed by a self-massage of the eyelids with Leveragein 1 or Leveragein 2. For this Blafasel 1 or Leveraging 2 the patient puts on the fingertips and soft circular motion parallel to the edges and in the direction of advanced close to the Ostia massages the glands of the eyelids, including the ciliary margin, 1-2 minutes. The choice of the type of Leverages depends on skin type. When the IRNA skin, diagnosed with demodicosis and expressed signs of inflammation use Blafasel 2, as the preparations of sulphur better remove excess fat, improve metabolism, eliminate inflammation and strengthen protivonematodoznae action hygienic procedures. The procedure is performed daily for 1-2 minutes, 2 times a day, morning and evening for one month, with the resumption of symptoms are repeated course with an interval of 1 month. Day, every 4 hours after the morning hygiene century, 3 times a day, carry out the installation in the conjunctival cavity tear replacement drug Sistan Balance. Another component of comprehensive treatment is gymnastics for the eyes in the form of blink - within 15 seconds, 3 times a day, in between installations classements. Clinical examples Example No. 1. Patient N., 54 years. Complaints of recurrent discomfort in both eyes, the feeling of "dryness", itching of the eyelids, worse in the evening. Anamnesis vitae: career-related work on the computer. OD VIS=0,8-0,9 Sph+1,0D=1,0 OS VIS=0,8-0,9 Sph+0,75D=1,0 At survey: OU - relaxed, eyelids slightly thickened, hypermonogenic, mouth duct marojevic glands clogged, when pressed discharge whitish, moves with difficulty, conjunctiva pale pink, cornea etc is transparent, front camera is of medium depth, moisture transparent, structural iris, pupil round shape in the center, pigment hem partially leached, lens transparent. The fundus of the eye: without features. The Schirmer test - OD - 10 mm; OS - 9 mm Sample burrowing OD - 7 mm; OS - 8 mm; Diagnosis: OU - Hypermetropia weak. Blepharoconjunctivitis form of dry eye syndrome. Treatment: within one month of daily twice a day was carried out by the hygiene century in the form of a warm compress with Blepharoceridae within 1-2 minutes and eyelids massage with Leveragein 1 within 1-2 minutes. Every 4 hours 3 times a day in the conjunctival cavity was installed lessentiel Sistan Balance, and in the intervals between installations carried out exercises for the eyes as blink for 15 seconds, 3 times a day. The course is 1 month. Visual inspection of month: at the time of inspection, complaints of discomfort does not show. Examination: the mouth marojevic glands open, when pressed on the area of the projection marojevic glands secret is separated easily, transparent. Performance test Schirmer improved by 2 mm, the samples Norn for 4 seconds, indicating that the recovery of functional status marojevic glands, the lipid layer of the tear film, therefore, about the effectiveness of therapy. Example No. 2. Patient T., aged 57. Complaints the periodic sense of "dryness" in both eyes, eyes on the street when Sunny and windy weather. Anamnesis vitae: Without features. VIS: OD=1,0;OS=1,0. At survey: OU - calm, thickened eyelids, mouth duct marojevic glands clogged, when pressed detachable transparent, thick, separated with difficulty, conjunctiva slightly hyperemic, the cornea is a transparent, dry spots, disappearing after blinking, the front camera is of medium depth, moisture transparent, structural iris, pupil round shape in the center, the lens - initial opacity in the posterior layers. The fundus of the eye: without features. The Schirmer test - OD - 12 mm; OS - 15 mm Sample burrowing OD - 5 sec; OS - 4 sec; Diagnosis: OU - Dysfunction marojevic glands. Blepharoconjunctivitis form of dry eye syndrome. Treatment: Install Sistan Balance 3 times a day for 2 weeks. Control examination after 2 weeks: At the time of inspection, said improvement. Complaints about tearing absent, saved complaints about the feeling of "dryness" in the eyes while working on the computer and watching TV. Treatment: continued instillation of drug Sistan Balance, added warm compresses with Blepharoceridae, followed by self-massage of the eyelids with Leveragein 2 in the morning and evening; exercises for the eyes with frequent mode blink in between installation preparation Sistan Balance. The course is 1 month. Visual inspection of h is rez month: at the time of inspection, complaints of discomfort not notes. Examination: the mouth marojevic glands open, when pressed on the area of the projection marojevic glands secret is separated easily, transparent. Performance test Schirmer improved by 3 mm, the samples Norn for 2 seconds, therefore, therapy was effective. Example No. 3. Patient A., 49. Complaints about the periodic feeling of dryness and foreign body in the eyes, aggravated by a high visual load. Anamnesis vitae: Professionalnaya harm - bus driver. VIS: OD=0.9 to 1.0; OS=1,0; At survey: OU - relaxed, eyelids hypermonogenic, mouth duct marojevic clogged glands on the inner surface of the eyelids telangiectasia, conjunctiva slightly hyperemic, the cornea is transparent in the Central zone, the front camera is of medium depth, moisture transparent, structural iris, pupil round shape in the center, the lens - initial opacity in the posterior layers. The fundus of the eye: without features. The Schirmer test - OD - 17 mm; OS - 16 mm Sample burrowing OD - 4 sec; OS - 6 sec; Diagnosis: OU - Blepharitis with dysfunction mebelieve glands. Blepharoconjunctivitis form of dry eye syndrome. Treatment: within one month of daily twice a day was carried out by the hygiene century in the form of a warm compress with Blepharoceridae within 1-2 minutes and eyelids massage with Leveragein 1 in techenie1 2 minutes. Every 4 hours 3 times a day in the conjunctival cavity was installed lessentiel Sistan Balance, and in the intervals between installations carried out exercises for the eyes as blink for 15 seconds, 3 times a day. The course is 1 month. Visual inspection of month: at the time of inspection, the patient noted significant improvement, complaints of discomfort does not show. Examination: the eyelids are normal thick, mouth marojevic glands open, when pressed on the area of the projection marojevic glands secret is separated easily, transparent. Performance standard Norn: OD - 9 s; OS - 10 sec. 1 month after the treatment, the patient is again asked for advice about the resumption of complaints at periodic feeling of dryness and foreign body in the eyes, aggravated by a high visual load. Recommended re-rate, against which the patient is again noted improvement. Therefore, due to the chronic course of the disease, it is recommended to conduct refresher courses offer therapy every month with an interval of one month. Thus, the proposed integrated method of treatment blepharoconjunctivitis forms of dry eye syndrome provides restoration of the functional state of the lipid layer of the tear is Lenka with the enhancement of protective functions tears and a corresponding reduction of the clinical manifestations of degenerative and inflammatory processes in centuries, conjunctiva and the cornea, easy to use. 1. The method of treatment blepharoconjunctivitis forms of dry eye syndrome, characterized in that within one month of daily twice daily conduct hygiene century in the form of a warm compress with Blepharoceridae within 1-2 minutes and eyelids massage with Leveragein 1 or Leveragein 2 within 1-2 minutes, every 4 hours 3 timesa day in the conjunctival cavity instilliruut lessentiel Sistan Balance, and in the intervals between instillation conduct exercises for the eyes as blink for 15 seconds, 3 times a day. 2. The method according to claim 1, characterized in that the course of treatment, repeat with an interval of 1 month.
|
© 2013-2014 Russian business network RussianPatents.com - Special Russian commercial information project for world wide. Foreign filing in English. |